Inhibitors | Comment | Organism | Structure |
---|---|---|---|
(4aR,10aS)-4a-[5-(4-bromophenyl)-1,3,4-oxadiazol-2-yl]-5,6-dihydroxy-1,1-dimethyl-7-(propan-2-yl)-2,3,4,4a,10,10a-hexahydrophenanthren-9(1H)-one | - |
Homo sapiens | |
(4aR,10aS)-4a-[5-[(1R)-1-aminoethyl]-1,3,4-oxadiazol-2-yl]-5,6-dihydroxy-1,1-dimethyl-7-(propan-2-yl)-2,3,4,4a,10,10a-hexahydrophenanthren-9(1H)-one | - |
Homo sapiens | |
(4bR,8aS)-4b-(5-acetyl-1,3,4-oxadiazol-2-yl)-8,8-dimethyl-2-(propan-2-yl)-5,6,7,8,8a,9-hexahydrophenanthrene-3,4,10(4bH)-trione | - |
Homo sapiens | |
(4bR,8aS)-4b-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-8,8-dimethyl-2-(propan-2-yl)-5,6,7,8,8a,9-hexahydrophenanthrene-3,4,10(4bH)-trione | - |
Homo sapiens | |
(4bR,8aS)-4b-(5-[(1S)-1-[(hydroxymethyl)amino]ethyl]-1,3,4-oxadiazol-2-yl)-8,8-dimethyl-2-(propan-2-yl)-4b,5,6,7,8,8a,9,10-octahydrophenanthrene-3,4-diol | - |
Homo sapiens | |
12-hydroxy-11,20-epoxyabieta-8(14),9(11),12-trien-20-one | - |
Homo sapiens | |
2-[11,12-dihydroxy-20-oxoabieta-8(14),9(11),12-trien-20-yl]hydrazine-1-carboxamide | - |
Homo sapiens | |
6,20-epoxyabieta-8,13-diene-7,11,12,20-tetrone | - |
Homo sapiens | |
7,20-epoxyabieta-8,13-diene-11,12-dione | - |
Homo sapiens | |
methyl 11,12-dihydroxy-7-(phenylsulfanyl)abieta-8(14),9(11),12-trien-20-oate | - |
Homo sapiens | |
methyl 11,12-dihydroxy-7-methoxyabieta-8(14),9(11),12-trien-20-oate | - |
Homo sapiens | |
methyl 11,12-dihydroxy-7-oxoabieta-8(14),9(11),12-trien-20-oate | - |
Homo sapiens | |
methyl 11,12-dihydroxyabieta-8(14),9(11),12-trien-20-oate | - |
Homo sapiens | |
methyl 7-[(2-hydroxyethyl)sulfanyl]-11,12-dioxoabieta-8,13-dien-20-oate | - |
Homo sapiens | |
N-acetyl-S-((4aR,10aS)-5,6-dihydroxy-7-isopropyl-4a-(methoxycarbonyl)-1,1-dimethyl-1,2,3,4,4a,9,10,10a-octahydrophenanthren-9-yl)-L-cysteine | - |
Homo sapiens | |
N-benzyl-11,12-dihydroxyabieta-8(14),9(11),12-trien-20-amide | - |
Homo sapiens | |
N-cycloheptyl-11,12-dihydroxyabieta-8(14),9(11),12-trien-20-amide | - |
Homo sapiens | |
tert-butyl [(1S)-1-[5-[(4aR,10aS)-5,6-dihydroxy-1,1-dimethyl-7-(propan-2-yl)-1,3,4,9,10,10a-hexahydrophenanthren-4a(2H)-yl]-1,3,4-oxadiazol-2-yl]ethyl]carbamate | - |
Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
(2E,6E)-farnesyl diphosphate + isopentenyl diphosphate | Homo sapiens | - |
diphosphate + geranylgeranyl diphosphate | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | O95749 | - |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
pancreatic cancer cell line | - |
Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
(2E,6E)-farnesyl diphosphate + isopentenyl diphosphate | - |
Homo sapiens | diphosphate + geranylgeranyl diphosphate | - |
? |
Synonyms | Comment | Organism |
---|---|---|
geranylgeranyl pyrophosphate synthase | - |
Homo sapiens |
HsGGPPS | - |
Homo sapiens |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
23 | - |
assay at | Homo sapiens |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
7.5 | - |
assay at | Homo sapiens |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.0055 | - |
pH 7.5, 23°C | Homo sapiens | methyl 11,12-dihydroxy-7-(phenylsulfanyl)abieta-8(14),9(11),12-trien-20-oate | |
0.0109 | - |
pH 7.5, 23°C | Homo sapiens | (4bR,8aS)-4b-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-8,8-dimethyl-2-(propan-2-yl)-5,6,7,8,8a,9-hexahydrophenanthrene-3,4,10(4bH)-trione | |
0.0123 | - |
pH 7.5, 23°C | Homo sapiens | (4bR,8aS)-4b-(5-acetyl-1,3,4-oxadiazol-2-yl)-8,8-dimethyl-2-(propan-2-yl)-5,6,7,8,8a,9-hexahydrophenanthrene-3,4,10(4bH)-trione | |
0.0147 | - |
pH 7.5, 23°C | Homo sapiens | 12-hydroxy-11,20-epoxyabieta-8(14),9(11),12-trien-20-one | |
0.0152 | - |
pH 7.5, 23°C | Homo sapiens | methyl 11,12-dihydroxyabieta-8(14),9(11),12-trien-20-oate | |
0.0154 | - |
pH 7.5, 23°C | Homo sapiens | N-acetyl-S-((4aR,10aS)-5,6-dihydroxy-7-isopropyl-4a-(methoxycarbonyl)-1,1-dimethyl-1,2,3,4,4a,9,10,10a-octahydrophenanthren-9-yl)-L-cysteine | |
0.0169 | - |
pH 7.5, 23°C | Homo sapiens | 7,20-epoxyabieta-8,13-diene-11,12-dione | |
0.0232 | - |
pH 7.5, 23°C | Homo sapiens | 6,20-epoxyabieta-8,13-diene-7,11,12,20-tetrone | |
0.0347 | - |
pH 7.5, 23°C | Homo sapiens | N-cycloheptyl-11,12-dihydroxyabieta-8(14),9(11),12-trien-20-amide | |
0.0354 | - |
pH 7.5, 23°C | Homo sapiens | methyl 11,12-dihydroxy-7-methoxyabieta-8(14),9(11),12-trien-20-oate | |
0.0375 | - |
pH 7.5, 23°C | Homo sapiens | tert-butyl [(1S)-1-[5-[(4aR,10aS)-5,6-dihydroxy-1,1-dimethyl-7-(propan-2-yl)-1,3,4,9,10,10a-hexahydrophenanthren-4a(2H)-yl]-1,3,4-oxadiazol-2-yl]ethyl]carbamate | |
0.0378 | - |
pH 7.5, 23°C | Homo sapiens | N-benzyl-11,12-dihydroxyabieta-8(14),9(11),12-trien-20-amide | |
0.0379 | - |
pH 7.5, 23°C | Homo sapiens | 2-[11,12-dihydroxy-20-oxoabieta-8(14),9(11),12-trien-20-yl]hydrazine-1-carboxamide | |
0.04 | - |
pH 7.5, 23°C | Homo sapiens | (4aR,10aS)-4a-[5-(4-bromophenyl)-1,3,4-oxadiazol-2-yl]-5,6-dihydroxy-1,1-dimethyl-7-(propan-2-yl)-2,3,4,4a,10,10a-hexahydrophenanthren-9(1H)-one | |
0.0432 | - |
pH 7.5, 23°C | Homo sapiens | (4bR,8aS)-4b-(5-[(1S)-1-[(hydroxymethyl)amino]ethyl]-1,3,4-oxadiazol-2-yl)-8,8-dimethyl-2-(propan-2-yl)-4b,5,6,7,8,8a,9,10-octahydrophenanthrene-3,4-diol | |
0.0436 | - |
pH 7.5, 23°C | Homo sapiens | methyl 11,12-dihydroxy-7-oxoabieta-8(14),9(11),12-trien-20-oate | |
0.0459 | - |
pH 7.5, 23°C | Homo sapiens | methyl 7-[(2-hydroxyethyl)sulfanyl]-11,12-dioxoabieta-8,13-dien-20-oate | |
0.0494 | - |
pH 7.5, 23°C | Homo sapiens | (4aR,10aS)-4a-[5-[(1R)-1-aminoethyl]-1,3,4-oxadiazol-2-yl]-5,6-dihydroxy-1,1-dimethyl-7-(propan-2-yl)-2,3,4,4a,10,10a-hexahydrophenanthren-9(1H)-one |
General Information | Comment | Organism |
---|---|---|
drug target | the enzyme is a target for treating bone resorption diseases and some cancers | Homo sapiens |